Viking Thera (VKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 769 | 2,140 | 9,497 | 327 | 756 |
| Marketable Securities | 13,336 | 15,350 | 12,162 | N/A | N/A |
| TOTAL | $15,202 | $18,932 | $22,270 | $360 | $774 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 238 | 80 | 0 | 2,408 | 2,270 |
| TOTAL | $238 | $80 | $N/A | $2,408 | $2,270 |
| Total Assets | $15,439 | $19,012 | $22,270 | $2,769 | $3,043 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,911 | 1,671 | 310 | 304 |
| Accounts payable and accrued liabilities | 592 | 402 | 1,008 | 1,879 | 1,831 |
| Accrued Expenses | N/A | 152 | 121 | 24,939 | 19,943 |
| Other current liabilities | N/A | 2,154 | 1,957 | 62 | 59 |
| TOTAL | $1,977 | $5,723 | $4,876 | $27,709 | $22,517 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,706 | 0 | 0 | 2,900 | 2,655 |
| TOTAL | $4,737 | $19 | $N/A | $2,900 | $2,655 |
| Total Liabilities | $6,714 | $5,742 | $4,876 | $30,608 | $25,172 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,684 | 9,678 | 9,783 | 9,783 | N/A |
| Retained earnings | -45,545 | -40,455 | -35,718 | -27,853 | -22,142 |
| Other shareholders' equity | -7 | -5 | -13 | 0 | 0 |
| TOTAL | $8,725 | $13,271 | $17,394 | $-27,839 | $-22,129 |
| Total Liabilities And Equity | $15,439 | $19,012 | $22,270 | $2,769 | $3,043 |